These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8610946)
1. Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Robertson JM; Burtt DS; Edmonds KL; Molina PL; Kiefe CI; Ellner JJ Ann Intern Med; 1996 May; 124(9):779-84. PubMed ID: 8610946 [TBL] [Abstract][Full Text] [Related]
2. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff. Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959 [TBL] [Abstract][Full Text] [Related]
4. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692 [TBL] [Abstract][Full Text] [Related]
5. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection. Villarino ME; Geiter LJ; Schulte JM; Castro KG AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS). Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806 [TBL] [Abstract][Full Text] [Related]
7. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206 [TBL] [Abstract][Full Text] [Related]
8. A 19-year follow-up of tuberculin reactors. Assessment of skin test reactivity and in vitro lymphocyte responses. Havlir DV; van der Kuyp F; Duffy E; Marshall R; Hom D; Ellner JJ Chest; 1991 May; 99(5):1172-6. PubMed ID: 2019174 [TBL] [Abstract][Full Text] [Related]
9. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982 [TBL] [Abstract][Full Text] [Related]
10. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand. Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097 [TBL] [Abstract][Full Text] [Related]
11. Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis. Tager IB; Kalaidjian R; Baldini L; Rocklin RE Am Rev Respir Dis; 1985 Feb; 131(2):214-20. PubMed ID: 3882032 [TBL] [Abstract][Full Text] [Related]
12. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon. Escobar AL; Coimbra CE; Camacho LA; Santos RV Int J Tuberc Lung Dis; 2004 Jan; 8(1):45-51. PubMed ID: 14974745 [TBL] [Abstract][Full Text] [Related]
13. Infliximab does not suppress the tuberculin skin test (purified protein derivative). Hatemi G; Melikoglu M; Fresko I; Masatlioglu S; Tascilar K; Yazici H J Rheumatol; 2007 Mar; 34(3):474-80. PubMed ID: 17299840 [TBL] [Abstract][Full Text] [Related]
14. The booster effect in two-step tuberculin testing among young adults in Montreal. Menzies R; Vissandjee B; Rocher I; St Germain Y Ann Intern Med; 1994 Feb; 120(3):190-8. PubMed ID: 8273982 [TBL] [Abstract][Full Text] [Related]
15. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Markowitz N; Hansen NI; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Wilcosky TC; Wallace JM; Rosen MJ; Reichman LB Ann Intern Med; 1997 Jan; 126(2):123-32. PubMed ID: 9005746 [TBL] [Abstract][Full Text] [Related]
16. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity. Hoft DF; Tennant JM Ann Intern Med; 1999 Jul; 131(1):32-6. PubMed ID: 10391813 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok. Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092 [TBL] [Abstract][Full Text] [Related]
18. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin. Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540 [TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture. Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218 [TBL] [Abstract][Full Text] [Related]
20. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]